São Paulo Medical Journal ()

Bone disease in patients with chronic kidney disease under conservative management

  • Carlos Perez Gomes,
  • Maria Inês Barreto Silva,
  • Maria Eugênia Leite Duarte,
  • David Dorigo,
  • Carla Cavalheiro da Silva Lemos,
  • Rachel Bregman

DOI
https://doi.org/10.1590/S1516-31802005000200010
Journal volume & issue
Vol. 123, no. 2
pp. 83 – 87

Abstract

Read online

CONTEXT AND OBJECTIVE: Few studies have focused on bone disease in patients with chronic kidney disease under conservative treatment. The objective was to evaluate bone disease in patients with chronic kidney disease. DESIGN AND SETTING: Case series, at the Nephrology Division, Hospital Universitário Pedro Ernesto. METHODS: 131 patients with creatinine clearance from 10 to 60 ml/min/1.73 m² were followed up for at least one year. Serum creatinine, albumin, calcium, phosphorus, alkaline phosphatase, total CO2 (tCO2), intact parathyroid hormone (iPTH), and alkaline phosphatase were measured. Creatinine clearance was calculated from 24-hour urine creatinine measurements and protein ingestion estimates from urea assays. RESULTS: Patients presenting creatinine clearance 144 pg/ml showed osteitis fibrosa (4), mild lesion (4) and high turnover (1). CONCLUSION: The present data suggest the importance of early control for iPTH and metabolic acidosis, among patients under conservative management for chronic kidney disease, in order to prevent complications related to bone disease.

Keywords